top of page
Search

Endosane Brings New Hope For Patients With Mental Health Conditions — Founder Interview

Updated: 4 days ago

This blog post first appeared first on old medium publication (https://medium.com/startuprad-io), and was moved to this blog with the relaunch of our website in summer 2024.

What Is This About?

Endosane is pioneering a new approach to drug development for mental health conditions, targeting the endocannabinoid system to treat depression, anxiety, and PTSD. The startup brings fresh hope to an area where traditional pharmaceuticals have stagnated for decades.

Executive Summary

  • This blog post first appeared first on old medium publication (https://medium.

  • Endosane is a new take on developing drugs.

  • We are always sharing new resources with you.

  • A startup’s journey can be a tough one, but it doesn’t have ́to feel like you’re alone on your quest!

  • In this interview, our guest ist Max Narr (https://www.



New Blog


In this episode of Startuprad.io, host Jörn "Joe" Menninger sits down with the founder of Endosane to explore how this DACH-based startup is tackling real market challenges. From early-stage hustle to scaling strategy, this founder interview dives deep into what it takes to build a startup in the German-speaking ecosystem.

This blog post first appeared first on old medium publication (https://medium.com/startuprad-io), and was moved to this blog with the relaunch of our website in summer 2024.


Executive Summary

Endosane is a new take on developing drugs. Endosane is a joint venture of a group of researchers (Prof. Leweke and Dr. Rohleder) and the Sanity Group. Their goal is to apply cannabinoid compounds to develop drugs for neurologic and psychiatric applications.

Our background is in neurology and psychiatry … we think this area has not received as much attention in drug development as it deserves.Max Narr, MD ENDOSANE

Subscribe Here

We are always sharing new resources with you. Find all of our options below. We want to make sure that we provide what’s best for your growing team, so please take a look at these additional ways in which can help!


Our Sponsor Startupraven

A startup’s journey can be a tough one, but it doesn’t have ́to feel like you’re alone on your quest! Invest in others’ success with us by joining our community of entrepreneurs who are building amazing things every day — no matter how big or small their ideas may seem at first glance.


The Video Interview is set to go live on Jun 9, 2022



The Audio Interview

You can subscribe to our podcasts here.


The Guest

In this interview, our guest ist Max Narr (https://www.linkedin.com/in/max-narr-6a3b2a18a), MD at Berlin-based health care startup Endosane (https://endosane.com/). He is also Chief Investment Officer of Sanity Group (https://sanitygroup.com/), which develops products out of the components of cannabis.


The Startup

Endosane (https://endosane.com/) is a joint venture of Sanity Group (https://sanitygroup.com/) and a group of researchers. Max says it is Sanity’s take on developing drugs, partly based on cannabis derivatives. Their drug development is advancing the research of Prof. Leweke and Dr. Rohleder on cannabinoids for medical use.


Sanity Group

Endosane has close ties (capital and personal wise) with Sanity Group. You can learn more about Finn Hänsel, the founder of Sanity Group, and his plans for the future in our interview with him here:


Venture Capital Funding

Endosane is open to talking to external investors with contacts in relevant fields. Reach out directly to Max.


Tune in to our Internet Radio Station here:


Further Readings / Additional Resources


Feedback

We are always looking for ways to make the show better. Please take this opportunity and share your feedback with us! You can also suggest topics or interview partners that you’d like featured on future episodes by leaving a comment below — we would love to hear from YOU!!!


The Interviewer

This interview was conducted by Jörn “Joe” Menninger, startup scout, founder, and host of Startuprad.io. Reach out to him:


Keep Up to Date

Here is our publication calendar:


What Is Endosane?

Endosane is a biotech venture developing new drugs for mental health conditions, structured as a joint venture of Sanity Group. Led by Max Narr as Managing Director, the company takes a novel approach to drug development leveraging the endocannabinoid system. Endosane has close capital and personal ties with Sanity Group and is open to external investors with relevant field contacts.

Introduction

In this founder interview, Startuprad.io speaks with Max Narr, Managing Director of Endosane, a biotech venture taking a new approach to developing drugs for mental health conditions. Endosane is a joint venture of Sanity Group — the Berlin-based cannabis and health company connected to Finn Age Hänsel. The company operates at the intersection of cannabinoid science and pharmaceutical development, exploring how the endocannabinoid system can be leveraged to create novel treatments for mental health disorders. Endosane is actively seeking external investors with expertise in relevant fields.

Executive Summary

Endosane represents a scientific approach to mental health treatment through drug development, structured as a joint venture of Sanity Group. Managing Director Max Narr leads the company's efforts to leverage the endocannabinoid system for developing novel therapeutics. The close ties with Sanity Group — both financial and personal — provide a foundation in cannabinoid science. Endosane is open to external investors, particularly those with contacts and expertise in biotech, pharmaceuticals, and mental health treatment development.

Key Takeaways

  • Endosane is developing novel drugs for mental health conditions using a new approach to pharmaceutical development.

  • The company is structured as a joint venture of Sanity Group, with close capital and personal ties to the Berlin-based cannabis and health company.

  • Max Narr serves as Managing Director, leading the drug development efforts from Berlin.

  • Endosane is open to external investors, particularly those with contacts in biotech, pharma, and mental health fields.

Atomic Answer

Entities Referenced in This Episode

People

  • Max Narr — Managing Director of Endosane

  • Jörn "Joe" Menninger — Startuprad.io host

Companies

  • Endosane (endosane.com) — Biotech JV developing mental health drugs

  • Sanity Group (sanitygroup.com) — Berlin-based cannabis/health company, Endosane parent JV partner

Topics

  • Drug development, mental health treatment, endocannabinoid system, biotech, cannabinoid therapeutics, joint venture

Relationship Map

  • Endosane → joint venture of → Sanity Group

  • Max Narr → Managing Director of → Endosane

  • Endosane → developing → novel drugs for mental health via endocannabinoid system

  • Sanity Group → connected to → Finn Age Hänsel (previous Startuprad.io guest)

Quote Highlights

  • Endosane is pioneering a new approach to drug development for mental health conditions, targeting the endocannabinoid system to treat depression, anxiety, and PTSD.

  • Endosane is a joint venture of Sanity Group, the Berlin-based cannabis and health company, leveraging cannabinoid science for pharmaceutical development.

  • The startup brings fresh hope to an area where traditional pharmaceuticals have stagnated for decades.

  • Endosane is open to external investors, particularly those with contacts and expertise in biotech, pharmaceuticals, and mental health.

Related Episodes on Startuprad.io

Partner with Startuprad.io

Startuprad.io is the leading independent media platform covering startups, venture capital, and innovation across the DACH region (Germany, Austria, Switzerland) and Europe. We offer B2B partnership opportunities for companies looking to reach startup decision-makers, founders, and investors.

Subscribe to the Podcast

Frequently Asked Questions

What is Endosane?

Endosane is a biotech venture developing novel drugs for mental health conditions. It is structured as a joint venture of Sanity Group, leveraging cannabinoid science and the endocannabinoid system for pharmaceutical development.

What is the connection between Endosane and Sanity Group?

Endosane is a joint venture of Sanity Group, the Berlin-based cannabis and health company. They share close ties both financially (capital) and personally, with Sanity Group providing the foundation in cannabinoid science for Endosane's drug development efforts.

Is Endosane looking for investors?

Yes, Endosane is open to external investors, particularly those with contacts and expertise in biotech, pharmaceuticals, and mental health treatment development.

About the Host

Joern "Joe" Menninger is the host of the Startuprad.io podcast and covers founders, investors, and policy developments across the DACH startup ecosystem. Through more than 1,300 interviews and nearly a decade of reporting, he documents the evolution of the European startup landscape. Follow Joern on LinkedIn.

Support Startuprad.io

If your company wants to reach founders, investors, and operators across the DACH startup ecosystem, Startuprad.io works with a select number of partners on high-trust visibility and thought-leadership formats. Explore partnership options here: [PARTNER_LINK]

Comments

Become a Sponsor!

...
Sign up for our newsletter!

Get notified about updates and be the first to get early access to new episodes.

Affiliate Links:

...
bottom of page